Use of potentially inappropriate medications and medications of concern in older adults with multiple myeloma

• Autor(a) principal: Silva,Paulo Vitor Rozario da
• Data de Publicação: 2024
• Outros Autores: Pádua,Cristiane Aparecida Menezes de, Machado,Taisa Roberta Lopes, Drummonda,Paula Lana de Miranda, Silveira,Lívia Pena, Malta,Jéssica Soares, Reis,Adriano Max Moreira
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Geriatrics, Gerontology and Aging (Online)
• Texto Completo: https://ggaging.com/details/1823
• topic: list of potentially inappropriate medications; older adults; multiple myeloma; cancer.

<p><b>OBJECTIVES:</b> To analyze the use of potentially inappropriate medications (PIMs) and medications used in supportive therapy that require caution in older adults with cancer, in addition to determining associated factors the agreement between criteria sets used to identify PIMs.<br> <b>METHODS:</b> This cross-sectional study included individuals with multiple myeloma aged &ge; 60 years who were undergoing outpatient treatment. PIMs were identified according to American Geriatric Society Beers 2019, PRISCUS 2.0, and Brazilian Consensus on Potentially Inappropriate Medicines criteria. Medications of concern were defined according to National Comprehensive Cancer Network criteria. Factors associated with the use of PIMs and medications of concern were identified using multiple logistic regression. The degree of agreement between the 3 criteria sets was measured using Cohen's kappa coefficient.<br> <b>RESULTS:</b> The frequency of PIM use was 52.29% according to American Geriatric Society Beers criteria, 62.74% according to Brazilian Consensus criteria, and 65.36% according to PRISCUS criteria, while 52.29% of the patients were using medications of concern. Agreement between American Geriatric Society Beers, PRISCUS, and Brazilian Consensus criteria was high, while it was excellent between Brazilian Consensus and PRISCUS criteria. In the final logistic regression model, polypharmacy was associated with PIM use according to each criteria set, as well as the use of medications of concern. <br> <b>CONCLUSIONS:</b> The frequency of PIMs and medications of concern was high. Agreement about PIM use between the American Geriatric Society Beers, Brazilian Consensus, and PRISCUS criteria was high or excellent. There was an independent association between polypharmacy and the use of PIMs and medications of concern by older patients with multiple myeloma.</p>